Esperion Therapeutics, Inc.

ESPR SEC CIK 0001434868 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$819.46M
Covers every share class this company has on file.
Insiders on file
1
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
Not available
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
Not available
insider-held value divided by market capitalisation

What Esperion Therapeutics, Inc. reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$403.14M
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$22.68M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
294
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at Esperion Therapeutics, Inc.

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

People who file insider reports against Esperion Therapeutics, Inc..
Insider Reported role Shares Value Last action
Eric Warren Other Executive 370,218 Not available S Open-market sale Apr 17, 2025 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Eric Warren sold 2,234 Esperion Therapeutics, Inc. (ESPR) shares for $5,429 on Dec 17, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Eric Warren sold 2,234 Esperion Therapeutics, Inc. (ESPR) shares for $5,429 on Dec 17, 2024
Date Insider Transaction Shares Price Value Filing
Dec 17, 2024 Eric Warren S Open-market sale 2,234 held after: 160,121 $2.43 $5,429 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 13 rows we hold, 0 are open-market purchases and 12 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for Esperion Therapeutics, Inc., newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Apr 17, 2025 Eric Warren S Open-market sale 108 $0.98 $106 SEC filing ↗
Mar 18, 2025 Eric Warren S Open-market sale 2,433 $1.49 $3.6K SEC filing ↗
Mar 14, 2025 Eric Warren A Grant or award 213,000 $0.00 $0 SEC filing ↗
Feb 19, 2025 Eric Warren S Open-market sale 239 $1.87 $447 SEC filing ↗
Jan 17, 2025 Eric Warren S Open-market sale 123 $2.26 $278 SEC filing ↗
Dec 17, 2024 Eric Warren S Open-market sale 2,234 $2.43 $5.4K SEC filing ↗
Nov 19, 2024 Eric Warren S Open-market sale 197 $2.17 $427 SEC filing ↗
Oct 17, 2024 Eric Warren S Open-market sale 107 $2.12 $227 SEC filing ↗
Sep 17, 2024 Eric Warren S Open-market sale 2,608 $1.78 $4.6K SEC filing ↗
Aug 19, 2024 Eric Warren S Open-market sale 211 $1.95 $411 SEC filing ↗
Jul 17, 2024 Eric Warren S Open-market sale 108 $2.59 $280 SEC filing ↗
Jun 18, 2024 Eric Warren S Open-market sale 2,540 $2.86 $7.3K SEC filing ↗
May 17, 2024 Eric Warren S Open-market sale 192 $2.48 $476 SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.